| Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study TR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ... The Lancet 399 (10326), 719-728, 2022 | 127 | 2022 |
| Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus M Ruscica, M Gomaraschi, G Mombelli, C Macchi, R Bosisio, ... Journal of Clinical Lipidology 8 (1), 61-68, 2014 | 106 | 2014 |
| Efficacy of lomitapide in the treatment of familial homozygous hypercholesterolemia: results of a real-world clinical experience in Italy L D’Erasmo, AB Cefalù, D Noto, A Giammanco, M Averna, P Pintus, ... Advances in therapy 34, 1200-1210, 2017 | 84 | 2017 |
| Spectrum of mutations in Italian patients with familial hypercholesterolemia: new results from the LIPIGEN study A Pirillo, K Garlaschelli, M Arca, M Averna, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 17-24, 2017 | 83 | 2017 |
| Familial hypercholesterolemia: the Italian atherosclerosis society network (LIPIGEN) M Averna, AB Cefalu, M Casula, D Noto, M Arca, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 11-16, 2017 | 80 | 2017 |
| Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial M Ruscica, C Pavanello, S Gandini, M Gomaraschi, C Vitali, C Macchi, ... European journal of nutrition 57, 499-511, 2018 | 73 | 2018 |
| High-density lipoprotein, lecithin: cholesterol acyltransferase, and atherosclerosis A Ossoli, C Pavanello, L Calabresi Endocrinology and metabolism 31 (2), 223-229, 2016 | 69 | 2016 |
| Appropriateness of statin prescription in the elderly M Ruscica, C Macchi, C Pavanello, A Corsini, A Sahebkar, CR Sirtori European journal of internal medicine 50, 33-40, 2018 | 66 | 2018 |
| Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning A Pina, S Helgadottir, RM Mancina, C Pavanello, C Pirazzi, T Montalcini, ... European journal of preventive cardiology 27 (15), 1639-1646, 2020 | 57 | 2020 |
| Autosomal recessive hypercholesterolemia: long-term cardiovascular outcomes L D’Erasmo, I Minicocci, A Nicolucci, P Pintus, JE Roeters Van Lennep, ... Journal of the American College of Cardiology 71 (3), 279-288, 2018 | 56 | 2018 |
| Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020 C Pavanello, L Calabresi Current opinion in lipidology 31 (4), 232-237, 2020 | 55 | 2020 |
| Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice … M Ruscica, C Pavanello, S Gandini, C Macchi, M Botta, D Dall’Orto, ... Nutrition journal 18, 1-9, 2019 | 55 | 2019 |
| Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study M Casula, E Olmastroni, A Pirillo, AL Catapano, M Arca, M Averna, ... Atherosclerosis 277, 413-418, 2018 | 55 | 2018 |
| Nutraceutical approaches to metabolic syndrome CR Sirtori, C Pavanello, L Calabresi, M Ruscica Annals of medicine 49 (8), 678-697, 2017 | 53 | 2017 |
| Dysfunctional HDL as a therapeutic target for atherosclerosis prevention A Ossoli, C Pavanello, E Giorgio, L Calabresi, M Gomaraschi Current medicinal chemistry 26 (9), 1610-1630, 2019 | 49 | 2019 |
| Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary prevention G Mombelli, R Bosisio, L Calabresi, P Magni, C Pavanello, F Pazzucconi, ... Journal of clinical lipidology 9 (2), 226-233, 2015 | 44 | 2015 |
| Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study L d’Erasmo, K Steward, AB Cefalù, A Di Costanzo, E Boersma, S Bini, ... European journal of preventive cardiology 29 (5), 832-841, 2022 | 42 | 2022 |
| Homozygous familial hypercholesterolemia in Italy: clinical and molecular features S Bertolini, S Calandra, M Arca, M Averna, AL Catapano, P Tarugi, ... Atherosclerosis 312, 72-78, 2020 | 41 | 2020 |
| Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in NAFLD patients and cell cultures M Gomaraschi, AL Fracanzani, P Dongiovanni, C Pavanello, E Giorgio, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2019 | 35 | 2019 |
| Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study M Casula, M Gazzotti, F Bonaiti, E OImastroni, M Arca, M Averna, ... Journal of Internal Medicine 290 (1), 116-128, 2021 | 34 | 2021 |
